NO20073239L - TNF-antagonister - Google Patents
TNF-antagonisterInfo
- Publication number
- NO20073239L NO20073239L NO20073239A NO20073239A NO20073239L NO 20073239 L NO20073239 L NO 20073239L NO 20073239 A NO20073239 A NO 20073239A NO 20073239 A NO20073239 A NO 20073239A NO 20073239 L NO20073239 L NO 20073239L
- Authority
- NO
- Norway
- Prior art keywords
- tnf
- polypeptides
- treatment
- binding
- tnf antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4726—Lectins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62934304P | 2004-11-22 | 2004-11-22 | |
DKPA200401813 | 2004-11-22 | ||
PCT/DK2005/000742 WO2006053568A1 (en) | 2004-11-22 | 2005-11-21 | Tnf antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20073239L true NO20073239L (no) | 2007-08-17 |
Family
ID=35840156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20073239A NO20073239L (no) | 2004-11-22 | 2007-06-22 | TNF-antagonister |
Country Status (10)
Country | Link |
---|---|
US (1) | US7820622B2 (de) |
EP (1) | EP1824878A1 (de) |
JP (1) | JP2008520214A (de) |
KR (1) | KR20070095296A (de) |
AU (1) | AU2005306168A1 (de) |
BR (1) | BRPI0518042A (de) |
CA (1) | CA2587948A1 (de) |
NO (1) | NO20073239L (de) |
NZ (1) | NZ555353A (de) |
WO (1) | WO2006053568A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ568809A (en) | 2005-12-22 | 2011-08-26 | Genentech Inc | Recovering and purification of VEGF proteins from prokaryotic cells using polyanionic agents |
ZA200900229B (en) | 2006-07-14 | 2010-04-28 | Genentech Inc | Refolding of recombinant proteins |
BRPI0719597A2 (pt) | 2006-11-22 | 2013-12-17 | Adnexus A Bristol Myers Squibb R & D Company | Produtos terapêuticos objetivados baseados em proteínas manipuladas para receptores de quinases de tirosina, incluindo igf-ir |
EP2072527A1 (de) | 2007-12-21 | 2009-06-24 | Altonabiotec AG | Fusionspolypeptide, die einen SHBG-Dimerisierungsbestandteil umfassen, und deren Verwendung |
JP2011520961A (ja) | 2008-05-22 | 2011-07-21 | ブリストル−マイヤーズ スクイブ カンパニー | 多価フィブロネクチンをベースとする足場ドメインタンパク質 |
WO2010042890A2 (en) * | 2008-10-10 | 2010-04-15 | Anaphore, Inc. | Polypeptides that bind trail-ri and trail-r2 |
US20110086806A1 (en) * | 2009-10-09 | 2011-04-14 | Anaphore, Inc. | Polypeptides that Bind IL-23R |
CN107969128A (zh) | 2015-04-17 | 2018-04-27 | 高山免疫科学股份有限公司 | 具有可调的亲和力的免疫调节蛋白 |
US11124558B2 (en) * | 2017-06-02 | 2021-09-21 | The Feinstein Institutes For Medical Research | Use of tetranectin and peptide agonists to treat inflammatory diseases |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9409768D0 (en) | 1994-05-16 | 1994-07-06 | Medical Res Council | Trimerising polypeptides |
ATE282092T1 (de) | 1997-06-11 | 2004-11-15 | Borean Pharma As | Trimerisierendes modul |
WO2002048189A2 (en) | 2000-12-13 | 2002-06-20 | Borean Pharma A/S | Combinatorial libraries of proteins having the scaffold structure of c-type lectin-like domains |
AU2003225416A1 (en) | 2002-06-25 | 2004-01-06 | Medical Patents Limited | Injection syringe having a retractable injection needle |
CA2503697A1 (en) | 2002-10-29 | 2004-05-13 | Borean Pharma A/S | Trimeric binding proteins for trimeric cytokines |
-
2005
- 2005-11-21 JP JP2007541691A patent/JP2008520214A/ja active Pending
- 2005-11-21 AU AU2005306168A patent/AU2005306168A1/en not_active Abandoned
- 2005-11-21 WO PCT/DK2005/000742 patent/WO2006053568A1/en active Application Filing
- 2005-11-21 US US11/719,942 patent/US7820622B2/en not_active Expired - Fee Related
- 2005-11-21 KR KR1020077013927A patent/KR20070095296A/ko not_active Application Discontinuation
- 2005-11-21 BR BRPI0518042-2A patent/BRPI0518042A/pt not_active Application Discontinuation
- 2005-11-21 EP EP05803991A patent/EP1824878A1/de not_active Withdrawn
- 2005-11-21 CA CA002587948A patent/CA2587948A1/en not_active Abandoned
- 2005-11-21 NZ NZ555353A patent/NZ555353A/en not_active IP Right Cessation
-
2007
- 2007-06-22 NO NO20073239A patent/NO20073239L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0518042A (pt) | 2008-10-28 |
WO2006053568A1 (en) | 2006-05-26 |
KR20070095296A (ko) | 2007-09-28 |
NZ555353A (en) | 2009-12-24 |
JP2008520214A (ja) | 2008-06-19 |
EP1824878A1 (de) | 2007-08-29 |
US7820622B2 (en) | 2010-10-26 |
US20090155843A1 (en) | 2009-06-18 |
CA2587948A1 (en) | 2006-05-26 |
AU2005306168A1 (en) | 2006-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20073239L (no) | TNF-antagonister | |
JP7128246B2 (ja) | 抗炎症活性を有するペプチド、及びそれを含む組成物 | |
JP7007333B2 (ja) | 抗炎症活性を有するペプチド、及びそれを含む組成物 | |
RU2381233C2 (ru) | Агонисты рецептора меланокортина | |
WO2004101611A3 (en) | Peptides that bind to the erythropoietin receptor | |
Carstens et al. | Structure–Activity Studies of Cysteine‐Rich α‐Conotoxins that Inhibit High‐Voltage‐Activated Calcium Channels via GABAB Receptor Activation Reveal a Minimal Functional Motif | |
EA201070623A1 (ru) | Конструкция из полипептидов однодоменных антител, применение композиции, ее содержащей, и способ лечения ревматоидного артрита | |
WO2006052723A3 (en) | G protein coupled receptor agonists and antagonists and methods of use | |
ATE417595T1 (de) | Keratin-bindende polypeptide | |
US20100022446A1 (en) | Use of Peptides in Combination with Surgical Intervention for the Treatment of Obesity | |
UA105625C2 (uk) | Пастка vegf і її терапевтичне застосування | |
NO20070496L (no) | Kimere proteiner og anvendelser derav. | |
CY1123997T1 (el) | Νεα μεταλλακτικη παραλλαγη αλβουμινης ανθρωπινου ορου | |
JP2010501191A5 (de) | ||
JP2009526756A5 (de) | ||
Garcia‐Redondo et al. | Vascular effects of egg white‐derived peptides in resistance arteries from rats. Structure–activity relationships | |
BRPI0714844B8 (pt) | molécula de ácido nucleico e seus usos, composição farmaceutica e complexo | |
MX2021010404A (es) | Anticuerpos que se unen a una forma escindida de calreticulina mutante, y agente de diagnostico, preventivo o terapeutico para las neoplasias mieloproliferativas. | |
NZ599114A (en) | Stable anti-tnfr1 polypeptides, antibody variable domains & antagonists | |
WO2011012609A3 (en) | Anti - tgf - beta receptor type ii single domain antibodies | |
CA2581110A1 (en) | Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions | |
ZA202301784B (en) | Crf2 receptor agonists and their use in therapy | |
WO2003002604A3 (en) | G protein coupled receptors and dna sequences thereof | |
EP2530090A3 (de) | Anti-IL-13R alpha 1-Antikörper und Verwendung davon | |
EA200801077A1 (ru) | Антагонисты взаимодействия pf4 и rantes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CREP | Change of representative |
Representative=s name: ZACCO NORWAY AS, POSTBOKS 2003 VIKA, 0125 OSLO, NO |
|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |